StemCell Therapy

USDA could soon oversee parts of federal animal biotechnology regulations as part of a recently announced advance notice of proposed rule making. Under Secretary for Marketing and Regulatory Programs Greg Ibach says the proposed transfer of regulatory oversight from the Food and Drug Administration would cover agricultural animals modified or produced by genetic engineering. What we're seeing through this process is for those adjustments that are made to animals, primarily for food, labor, fiber, that we would have those regulatory authorities moved over to USDA APHIS directly providing that oversight under their animal health statutes. And the Food Safety and Inspection Service would conduct pre slaughter, food safety risk assessments. Usda and FDA would work together to develop a modernized regulatory framework that is risk based and scientifically sound. The proposed rulemaking is currently under a 60 day comment period. The FDA and USDA have sat down and spent months talking about how we might regulate animal biotech. And advanced notice of proposed rulemaking will set forth some parameters. But it's really asking the industry, are we on the right track? Have the framework that we're putting together? Will this work for you? Is this something that can help us move things through the regulatory process in a timely manner? Is this something that consumers can understand and have confidence in? So it's going to be very important for the industry, the developers, as well as the consumers, as well as farmers to weigh in, to let USDA and FDA know how they feel about this proposed framework.

See original here:
Animal bio-tech - AG INFORMATION NETWORK OF THE WEST - AGInfo Ag Information Network Of The West

This entry was posted on January 12, 2021 at 3:55 am and is filed under Genetic Engineering. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |